ArticleMolecular medicine (Cambridge, Mass.)2025
Molecular mechanisms of α-syn abnormal phase separation in cognitive impairment induced by chronic intermittent hypoxia and the neuroprotective effects of Danshensu methyl ester.
Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Correction: Molecular mechanisms of α-syn abnormal phase separation in cognitive impairment induced by chronic intermittent hypoxia and the neuroprotective effects of Danshensu methyl ester.Molecular medicine (Cambridge, Mass.) · 2026Article
- Synergistic anti-tumor activity of andrographolide and gemcitabine in intrahepatic cholangiocarcinoma through inhibition of RRM2 and the JAK/STAT3 pathway.Cancer chemotherapy and pharmacology · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
18 authors.
Funding
Abstract
The pathological association between α-synuclein (α-syn) deposition and neurodegeneration or cognitive dysfunction has been extensively studied for decades, but significant progress has yet to be achieved in clinical translation. Recently, the introduction of phase separation theory has provided a new perspective for elucidating the molecular mechanisms of α-syn deposition. We made the first discovery that chronic intermittent hypoxia (CIH) exposure induced fear memory deficits by damaging dopaminergic neurons in the ventral tegmental area (VTA). In vivo experiments showed that CIH exposure significantly increased α-syn expression and caused its abnormal deposition in the VTA, leading to neuron dysfunction. Furthermore, inhibiting α-syn expression effectively mitigated neuronal damage and fear memory deficits. Using an intermittent hypoxia (IH) model, we found that abnormal phase separation of α-syn mediates the transition from soluble state to fibrous state, which is the core mechanism of its deposition. α-syn phase separation is regulated by various factors, and we focused on reactive oxygen species (ROS), which were closely associated with α-syn liquid-liquid phase separation (LLPS) and notably altered in CIH/IH conditions. The results showed that CIH-induced ROS promoted the conversion of α-syn-EGFP phase separation droplets to fibrillar state. Moreover, in vitro experiments confirmed that hydrogen peroxide (H₂O₂) treatment induced abnormal phase separation of α-syn, while the antioxidant monomer drug Danshensu methyl ester (DME) effectively inhibited this process. Furthermore, in CIH and IH models, DME intervention significantly reduced ROS levels, inhibited α-syn abnormal phase separation, decreased intraneuronal α-syn deposition, and ultimately improved dopaminergic neuron damage and cognitive function. This study reveals that ROS-regulated abnormal phase separation of α-syn is a novel mechanism underlying CIH-induced neuron damage and might provide insights for the clinical treatment of related cognitive disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.